Is Ozempic the same as Wegovy?

They contain the same active ingredient (semaglutide) and are made by the same manufacturer (Novo Nordisk), but they're separately FDA-approved products with different labeled uses and different maximum doses. Ozempic is approved for type 2 diabetes with max 2mg/week. Wegovy is approved for chronic weight management with max 2.4mg/week.

Can I get Ozempic for weight loss?

Some providers prescribe Ozempic off-label for weight loss, but this is increasingly difficult because (1) insurance typically only covers Ozempic for diabetes, (2) off-label prescribing puts providers at higher scrutiny, and (3) Wegovy is now more widely available. For weight loss specifically, Wegovy or Zepbound are the on-label choices.

Which is cheaper, Ozempic or Wegovy?

Both have similar list prices (around $1,000-$1,350/month cash), but insurance coverage differs significantly. Ozempic is more likely to be covered for diabetes patients, while Wegovy is more likely to be covered for weight loss patients. For cash-paying patients, compounded semaglutide is much cheaper than either brand.

Do Ozempic and Wegovy have the same side effects?

Yes - they share the same side effect profile because they're the same active ingredient. The most common are nausea, diarrhea, vomiting, constipation, abdominal pain, and reduced appetite. Wegovy users may experience slightly more side effects at peak dosing due to the higher 2.4mg target dose, but individual responses vary significantly.

Ozempic vs Wegovy: What's Actually Different (2026 Guide)

If you've spent any time researching GLP-1 medications, you've probably wondered why Ozempic and Wegovy are both everywhere. Same company. Same drug. Different names. Different coverage. What's going on?

Here's the plain-English breakdown of what's actually different between them in 2026.

They're the Same Drug - Technically

Both Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. The molecule is identical. The manufacturing plant is the same. The injection is the same.

What's different is everything around the molecule.

Different FDA Approvals

This is the central difference, and it cascades into everything else.

	Ozempic	Wegovy
FDA-approved for	Type 2 diabetes	Chronic weight management
Approved in	2017	2021
Labeled patient	Adults with T2D	BMI 30+, or BMI 27+ with weight-related condition
Max dose	2mg weekly	2.4mg weekly
Recent expansion	Cardiovascular risk reduction (2020)	Cardiovascular risk reduction (2024)

The FDA approval determines what the drug is officially "for," which determines:

Which doses exist (Wegovy goes higher)
What insurance will cover
What the package label claims
What providers can prescribe on-label

Different Doses and Titration

Both medications start the same and diverge at the top end:

Ozempic doses: 0.25mg, 0.5mg, 1mg, 2mg (max)
Wegovy doses: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg (max)

Patients on Ozempic top out at 2mg. Patients on Wegovy can go to 2.4mg. That 0.4mg difference matters: clinical trials for weight loss used the 2.4mg dose, which is why Wegovy's label reflects the trial design.

Also, Wegovy has a pre-filled pen for each specific dose (you throw it away after four weekly doses), while Ozempic uses a multi-dose pen you adjust yourself.

Different Cost Structure (Sort Of)

List prices are similar:

Ozempic: ~$1,000-$1,100/month
Wegovy: ~$1,349/month

But insurance coverage differs dramatically:

For a diabetes patient, Ozempic is usually easier to get covered because it's on-label. For a weight loss patient, Wegovy is usually easier to get covered because weight management is its on-label use. Commercial insurers are increasingly willing to cover Wegovy now that the cardiovascular risk reduction indication opened in 2024.

For cash-paying patients: compounded semaglutide (which doesn't carry either brand name) is available through telehealth providers at $150-$350/month, significantly cheaper than either brand.

Different Telehealth Experience

Most reputable telehealth weight-loss platforms don't prescribe Ozempic off-label anymore. It's too much regulatory heat and insurance friction. What you'll typically see offered:

Wegovy (branded, for patients with insurance coverage)
Compounded semaglutide (for cash-paying patients)
Zepbound or Mounjaro or compounded tirzepatide (the tirzepatide alternatives)

If a telehealth platform prominently advertises "Ozempic for weight loss," treat that as a yellow flag. The more regulated, higher-quality providers are pushing patients toward Wegovy for on-label use or compounded semaglutide for cash pricing.

Effectiveness: The Same (Because It's the Same Drug)

Clinical trial data:

Wegovy (STEP trials): Average 14.9% body weight loss at 68 weeks on 2.4mg
Ozempic (off-label at 2mg): Generally less weight loss in trials, but studies are confounded because they're primarily diabetes-focused

The difference in trial outcomes reflects the higher Wegovy dose, not a difference in molecular effectiveness. Patients who take 2mg semaglutide (whether it's called Ozempic, Wegovy, or compounded) will get similar results. Patients who take 2.4mg will get more.

Which One Should You Ask Your Provider About?

If you have type 2 diabetes: Ozempic. That's what it's for. Insurance will likely cover it.

If you have obesity (BMI 30+) or overweight with weight-related conditions (BMI 27+ with diabetes, hypertension, sleep apnea, cardiovascular disease): Wegovy. That's its on-label use.

If you're cash-paying: Compounded semaglutide through a reputable telehealth provider. You'll get the same molecule at roughly a third of the cost. Just verify the pharmacy is 503A or 503B and disclosed.

If you're curious about tirzepatide alternatives: See our Mounjaro vs Zepbound guide for the same comparison on the Eli Lilly side.

The Bottom Line

Ozempic and Wegovy are the same drug with different FDA labels. The distinction matters for insurance coverage, max dosing, and provider willingness to prescribe. But mechanically, they're semaglutide either way. Compare providers on price, support, and pharmacy credibility - not on whether they say "Ozempic" or "Wegovy" in their marketing.